AKT1 and Alzheimer disease: Ali et al. provided evidence that anthocyanin, derived from microbial metabolism, modulates p-PI3K/Akt/GSK3β pathways, decreasing amyloid beta oligomer in both in vitro and in vivo models of a model of AD (APP/PS1) [162].